Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Reprocessors, OEMs Will Operate On "Level Playing Field," Feigal Testifies

This article was originally published in The Gray Sheet

Executive Summary

FDA Center for Devices and Radiological Health Director David Feigal promised the House Commerce/ Oversight and Investigations Subcommittee Feb. 10 that new regulations on reuse of single-use devices will be equally applied to manufacturers and reprocessors.

You may also be interested in...



Court Decision Opens Door For Trademark Suits In Device Refurbishing, Reuse

A recent federal court decision against Surgical Technologies, Inc., a medical device refurbisher, could form the basis for a legal challenge of single-use device reprocessors on trademark issues

Court Decision Opens Door For Trademark Suits In Device Refurbishing, Reuse

A recent federal court decision against Surgical Technologies, Inc., a medical device refurbisher, could form the basis for a legal challenge of single-use device reprocessors on trademark issues

Open-But-Unused SUD Reprocessing Will Not Be Pursued - FDA's Kessler

FDA expects to issue a final guidance by August on its approach to regulate reprocessing of single-use devices (SUDs) by third-party facilities, according to Larry Kessler, director of the Center for Devices and Radiological Health's Office of Surveillance and Biometrics.

Related Content

UsernamePublicRestriction

Register

LL018264

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel